The round was jointly led by Mercia Ventures and Smedvig Ventures to power product development and international growth.
"It is widely accepted that human error is the most prevalent vector for cyber-attacks and is poorly protected against by ineffective training programmes. Advanced analytics applied to real-time behavioural data presents an original approach for CISOs to control human cyber risk. CultureAI is pioneering this with its market-leading software, offering immediate visibility and mitigation of vulnerabilities. James has an incredible reputation as a thought leader in the space and we are excited to partner with him and his team alongside Mercia Ventures."
The Series A round was co-led by White Star Capital and MMC Ventures to fund expansion into Southeast Asia.
"We invest in game-changing innovators and as the digital asset space continues to mature, Haruko is leading the way in ensuring institutions are equipped to embrace these new opportunities. We’re delighted to continue our partnership with Haruko and its experienced founders as they embark on the next phase of their strategic growth journey."
The oversubscribed round was led by Heartcore Capital with backing from Eka Ventures and angel investors.
"It was a delight to experience such overwhelming interest from investors enthusiastic about the future of flight-free travel when raising our Series A. I’m thrilled that in Heartcore and Eka we’ve found partners who believe in the joy of journey-based holidays and the potential of JourneyAI to change travel for the better,"
NovaQuest led the financing round, which drew participation from eight investors across three continents.
"Following on from our successful seed funding round from Gabriel Investments and Equity Gap, Series A is an important milestone in our global growth plans, as we seek to improve health outcomes for animals through earlier disease diagnosis using revolutionary biomarker technology and artificial intelligence. The geographical spread of this investment round reflects the global opportunity for MI:RNA to deploy our platform for better outcomes for pets."
The oversubscribed round saw backing from investors including André Hoffmann and Oxford Science Enterprises to expand environmental reporting tools.
"It has been truly exciting to see the level of investor interest in our company, particularly in a less-than-optimal fundraising environment globally,"
